Translations:Vitamin B12/54/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
FuzzyBot (talk | contribs)
Importing a new version from external source
 
(No difference)

Latest revision as of 20:15, 5 April 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Vitamin B12)
== Drug interactions ==
===H<sub>2</sub>-receptor antagonists and proton-pump inhibitors===
Gastric acid is needed to release vitamin B<sub>12</sub> from protein for absorption. Reduced secretion of [[gastric acid]] and [[pepsin]], from the use of [[H2 antagonist|H<sub>2</sub> blocker]] or [[proton-pump inhibitor]] (PPI) drugs, can reduce absorption of protein-bound (dietary) vitamin B<sub>12</sub>, although not of supplemental vitamin B<sub>12</sub>. H<sub>2</sub>-receptor antagonist examples include [[cimetidine]], [[famotidine]], [[nizatidine]], and [[ranitidine]]. PPIs examples include [[omeprazole]], [[lansoprazole]], [[rabeprazole]], [[pantoprazole]], and [[esomeprazole]]. Clinically significant vitamin B<sub>12</sub> deficiency and megaloblastic anemia are unlikely, unless these drug therapies are prolonged for two or more years, or if in addition the person's dietary intake is below recommended levels. Symptomatic vitamin deficiency is more likely if the person is rendered [[achlorhydria|achlorhydric]] (a complete absence of gastric acid secretion), which occurs more frequently with proton pump inhibitors than H<sub>2</sub> blockers.

Drug interactions

H2-receptor antagonists and proton-pump inhibitors

Gastric acid is needed to release vitamin B12 from protein for absorption. Reduced secretion of gastric acid and pepsin, from the use of H2 blocker or proton-pump inhibitor (PPI) drugs, can reduce absorption of protein-bound (dietary) vitamin B12, although not of supplemental vitamin B12. H2-receptor antagonist examples include cimetidine, famotidine, nizatidine, and ranitidine. PPIs examples include omeprazole, lansoprazole, rabeprazole, pantoprazole, and esomeprazole. Clinically significant vitamin B12 deficiency and megaloblastic anemia are unlikely, unless these drug therapies are prolonged for two or more years, or if in addition the person's dietary intake is below recommended levels. Symptomatic vitamin deficiency is more likely if the person is rendered achlorhydric (a complete absence of gastric acid secretion), which occurs more frequently with proton pump inhibitors than H2 blockers.